Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 1;44(12):e83-e87.
doi: 10.1097/IAE.0000000000004266. Epub 2024 Nov 12.

Reply

David S Boyer  1 , Marion R Munk  2   3   4 , Stephanie E Tedford  5 , Cindy L Croissant  5 , Rene Rückert  5 , Clark E Tedford  5
Affiliations

Reply

David S Boyer et al. Retina. .
No abstract available

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Macular drusen volume following photobiomodulation treatment. A. Submitted table information (correct). B. Published table information.
See this image and copyright information in PMC

References

    1. Leng T, Schwartz J, Nimke D, et al. . Dry age-related macular degeneration: distribution of visual acuity and progression risk in a large registry. Ophthalmol Ther 2023;12:325–340. - PMC - PubMed
    1. Schneiderman T, Gonzalez V, Boyer D, et al. . Photobiomodulation using the valeda multiwavelength light delivery system demonstrates significant reduction in risk for vision loss and onset of geographic atrophy in dry age-related macular degeneration. IOVS. Presented at the ARVO Meeting; May 5–9, 2024; Seattle, WA.
    1. Finger RP, Wickremasinghe SS, Baird PN, Guymer RH. Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration. Surv Ophthalmol 2014;59:1–18. - PubMed
    1. Dugel PU, Hillenkamp J, Sivaprasad S, et al. . Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials. Clin Ophthalmol 2016;10:1103–1110. - PMC - PubMed
    1. Burton B, Parodi MB, Jürgens I, et al. . LIGHTSITE II randomized multicenter trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration. Ophthalmol Ther 2023;12:953–968. - PMC - PubMed